

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal rod cell development (GO:0046548) | 7.83579099 |
| 2 | retinal ganglion cell axon guidance (GO:0031290) | 7.42935384 |
| 3 | retinal cone cell development (GO:0046549) | 7.41253026 |
| 4 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 7.06514455 |
| 5 | substrate-independent telencephalic tangential migration (GO:0021826) | 7.06514455 |
| 6 | neuronal ion channel clustering (GO:0045161) | 5.62136810 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.50544928 |
| 8 | cerebellar granule cell differentiation (GO:0021707) | 5.26627375 |
| 9 | presynaptic membrane organization (GO:0097090) | 5.21238837 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.21016856 |
| 11 | presynaptic membrane assembly (GO:0097105) | 5.18234739 |
| 12 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 5.12564162 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.11690621 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.08318786 |
| 15 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.03205760 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.93222825 |
| 17 | glutamate secretion (GO:0014047) | 4.92739906 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.90212759 |
| 19 | vocalization behavior (GO:0071625) | 4.81221463 |
| 20 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.80453168 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67113477 |
| 22 | prepulse inhibition (GO:0060134) | 4.63694254 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.58958148 |
| 24 | glycerophospholipid catabolic process (GO:0046475) | 4.58706623 |
| 25 | glomerulus development (GO:0032835) | 4.55120205 |
| 26 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.51842941 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.48229965 |
| 28 | neuronal action potential propagation (GO:0019227) | 4.45250092 |
| 29 | positive regulation of action potential (GO:0045760) | 4.36984540 |
| 30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.35566495 |
| 31 | axonal fasciculation (GO:0007413) | 4.27366111 |
| 32 | behavioral response to nicotine (GO:0035095) | 4.27065731 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.26195140 |
| 34 | protein localization to synapse (GO:0035418) | 4.21511580 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 4.21017292 |
| 36 | central nervous system myelination (GO:0022010) | 4.21017292 |
| 37 | eye photoreceptor cell development (GO:0042462) | 4.15710274 |
| 38 | neurotransmitter secretion (GO:0007269) | 4.09171334 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 4.07428416 |
| 40 | postsynaptic membrane organization (GO:0001941) | 4.04629784 |
| 41 | negative regulation of JUN kinase activity (GO:0043508) | 4.04290408 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 4.02666083 |
| 43 | response to histamine (GO:0034776) | 3.98486628 |
| 44 | retina development in camera-type eye (GO:0060041) | 3.97138059 |
| 45 | neuron recognition (GO:0008038) | 3.96281019 |
| 46 | positive regulation of synapse assembly (GO:0051965) | 3.96022770 |
| 47 | adult walking behavior (GO:0007628) | 3.93697996 |
| 48 | photoreceptor cell development (GO:0042461) | 3.92380662 |
| 49 | cell differentiation involved in metanephros development (GO:0072202) | 3.92015219 |
| 50 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91295601 |
| 51 | nucleobase catabolic process (GO:0046113) | 3.91117074 |
| 52 | * cranial nerve development (GO:0021545) | 3.90431333 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.90209543 |
| 54 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.89735575 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.84871475 |
| 56 | behavioral response to cocaine (GO:0048148) | 3.84682564 |
| 57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79158257 |
| 58 | regulation of glutamate secretion (GO:0014048) | 3.78203543 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.76416584 |
| 60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.73016209 |
| 61 | nephron epithelium morphogenesis (GO:0072088) | 3.72744763 |
| 62 | nephron tubule morphogenesis (GO:0072078) | 3.72744763 |
| 63 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.71506936 |
| 64 | adaptation of signaling pathway (GO:0023058) | 3.71052289 |
| 65 | regulation of synaptic vesicle transport (GO:1902803) | 3.70761901 |
| 66 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.70129186 |
| 67 | axon extension (GO:0048675) | 3.68971354 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.67255204 |
| 69 | locomotory exploration behavior (GO:0035641) | 3.66884974 |
| 70 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.64173206 |
| 71 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.64173206 |
| 72 | negative regulation of amino acid transport (GO:0051956) | 3.61388804 |
| 73 | retina layer formation (GO:0010842) | 3.58347934 |
| 74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55655133 |
| 75 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.54757370 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.52667180 |
| 77 | regulation of postsynaptic membrane potential (GO:0060078) | 3.49076525 |
| 78 | layer formation in cerebral cortex (GO:0021819) | 3.48859012 |
| 79 | long-term synaptic potentiation (GO:0060291) | 3.42496625 |
| 80 | chemosensory behavior (GO:0007635) | 3.34671634 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.34501506 |
| 82 | neuron projection extension (GO:1990138) | 3.33780008 |
| 83 | histone H3-K9 methylation (GO:0051567) | 3.32437164 |
| 84 | regulation of neurotransmitter secretion (GO:0046928) | 3.31486225 |
| 85 | synaptic vesicle maturation (GO:0016188) | 3.30980205 |
| 86 | ATP synthesis coupled proton transport (GO:0015986) | 3.30802069 |
| 87 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.30802069 |
| 88 | neurotransmitter transport (GO:0006836) | 3.30066013 |
| 89 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29353416 |
| 90 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.28093760 |
| 91 | gamma-aminobutyric acid transport (GO:0015812) | 3.24963881 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.20521795 |
| 93 | female mating behavior (GO:0060180) | 3.19882739 |
| 94 | head development (GO:0060322) | 3.18384654 |
| 95 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.17859524 |
| 96 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.17830836 |
| 97 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.17830836 |
| 98 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.17437750 |
| 99 | regulation of synapse structural plasticity (GO:0051823) | 3.15400669 |
| 100 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.15055082 |
| 101 | negative regulation of axon guidance (GO:1902668) | 3.12619073 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.12017809 |
| 103 | response to vitamin E (GO:0033197) | 3.11784757 |
| 104 | pancreas development (GO:0031016) | 3.11326905 |
| 105 | establishment of mitochondrion localization (GO:0051654) | 3.09110059 |
| 106 | hypothalamus development (GO:0021854) | 3.08709442 |
| 107 | histone H3-K9 modification (GO:0061647) | 3.08619834 |
| 108 | regulation of sarcomere organization (GO:0060297) | 3.08119450 |
| 109 | regulation of female receptivity (GO:0045924) | 3.08025679 |
| 110 | positive regulation of membrane potential (GO:0045838) | 3.07316608 |
| 111 | dendrite development (GO:0016358) | 3.06990061 |
| 112 | atrial cardiac muscle cell action potential (GO:0086014) | 3.06312102 |
| 113 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.05014164 |
| 114 | regulation of synapse maturation (GO:0090128) | 3.03827390 |
| 115 | negative regulation of dendrite development (GO:2000171) | 3.03055562 |
| 116 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02214758 |
| 117 | regulation of action potential (GO:0098900) | 3.01890730 |
| 118 | synaptic transmission, cholinergic (GO:0007271) | 3.00347922 |
| 119 | synapse assembly (GO:0007416) | 3.00141408 |
| 120 | negative regulation of sodium ion transport (GO:0010766) | 2.99838506 |
| 121 | regulation of growth hormone secretion (GO:0060123) | 2.99298700 |
| 122 | regulation of neurotransmitter levels (GO:0001505) | 2.99014792 |
| 123 | regulation of astrocyte differentiation (GO:0048710) | 2.97744805 |
| 124 | regulation of synapse assembly (GO:0051963) | 2.95767106 |
| 125 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.95231072 |
| 126 | renal tubule morphogenesis (GO:0061333) | 2.95043393 |
| 127 | inner ear receptor stereocilium organization (GO:0060122) | 2.94495996 |
| 128 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94425124 |
| 129 | righting reflex (GO:0060013) | 2.94354524 |
| 130 | transmission of nerve impulse (GO:0019226) | 2.93541765 |
| 131 | transferrin transport (GO:0033572) | 2.90284765 |
| 132 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89173798 |
| 133 | photoreceptor cell maintenance (GO:0045494) | 2.88523411 |
| 134 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.88147807 |
| 135 | regulation of synaptic plasticity (GO:0048167) | 2.87605414 |
| 136 | mechanosensory behavior (GO:0007638) | 2.87375755 |
| 137 | detection of calcium ion (GO:0005513) | 2.86014414 |
| 138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85607154 |
| 139 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.85567589 |
| 140 | olfactory bulb development (GO:0021772) | 2.85496717 |
| 141 | cell differentiation in hindbrain (GO:0021533) | 2.85290550 |
| 142 | exploration behavior (GO:0035640) | 2.84875416 |
| 143 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.84730500 |
| 144 | fear response (GO:0042596) | 2.84355654 |
| 145 | synapse organization (GO:0050808) | 2.84256392 |
| 146 | cell migration in hindbrain (GO:0021535) | 2.82312612 |
| 147 | synaptic vesicle endocytosis (GO:0048488) | 2.82290656 |
| 148 | membrane hyperpolarization (GO:0060081) | 2.81468423 |
| 149 | calcium ion-dependent exocytosis (GO:0017156) | 2.80003428 |
| 150 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.78466042 |
| 151 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.78199433 |
| 152 | appendage development (GO:0048736) | 2.74351623 |
| 153 | limb development (GO:0060173) | 2.74351623 |
| 154 | positive regulation of male gonad development (GO:2000020) | 2.74197201 |
| 155 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.73502962 |
| 156 | axon extension involved in axon guidance (GO:0048846) | 2.73502962 |
| 157 | positive regulation of dendritic spine development (GO:0060999) | 2.71312889 |
| 158 | male sex determination (GO:0030238) | 2.70195238 |
| 159 | gastrulation with mouth forming second (GO:0001702) | 2.69942531 |
| 160 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.68411205 |
| 161 | regulation of meiosis I (GO:0060631) | 2.67052407 |
| 162 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.67002370 |
| 163 | intraciliary transport (GO:0042073) | 2.65029850 |
| 164 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.64126344 |
| 165 | auditory receptor cell stereocilium organization (GO:0060088) | 2.62104843 |
| 166 | nerve growth factor signaling pathway (GO:0038180) | 2.61826397 |
| 167 | meiotic chromosome segregation (GO:0045132) | 2.60048476 |
| 168 | piRNA metabolic process (GO:0034587) | 2.59794123 |
| 169 | neuron migration (GO:0001764) | 2.58592321 |
| 170 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.58548622 |
| 171 | mitochondrion transport along microtubule (GO:0047497) | 2.58548622 |
| 172 | artery development (GO:0060840) | 2.57089495 |
| 173 | detection of temperature stimulus (GO:0016048) | 2.56974860 |
| 174 | vitamin D metabolic process (GO:0042359) | 2.52278530 |
| 175 | activation of MAPKKK activity (GO:0000185) | 2.51413655 |
| 176 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.50040049 |
| 177 | regulation of dopamine secretion (GO:0014059) | 2.49833246 |
| 178 | bone remodeling (GO:0046849) | 2.48994073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.44295360 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.39082320 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.58816375 |
| 4 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.02941940 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.99591384 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.86295727 |
| 7 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.86211451 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.80680205 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.76583584 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73140688 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71368169 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.51873609 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48938663 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46929379 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46929379 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46643974 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44849547 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44631431 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44612694 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.35354815 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.19831359 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.12883866 |
| 23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07456569 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06170492 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03130740 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01797503 |
| 27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99688258 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98391258 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96256704 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96251293 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93420719 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.90975973 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89831480 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87253155 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.83780678 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81592883 |
| 37 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.78519225 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77572153 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76056453 |
| 40 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75714413 |
| 41 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.71884984 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70675107 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61333170 |
| 44 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.58709635 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57031397 |
| 46 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.56267921 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51111458 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50632476 |
| 49 | NFYB_21822215_ChIP-Seq_K562_Human | 1.48273101 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48252404 |
| 51 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.45766394 |
| 52 | TBL1_22424771_ChIP-Seq_293T_Human | 1.44211524 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44205513 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40879701 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40011985 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39775025 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39357375 |
| 58 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.37504157 |
| 59 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.35706142 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35043027 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35021621 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34995389 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33848354 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32526279 |
| 65 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32266103 |
| 66 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32257501 |
| 67 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.31860955 |
| 68 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.31226872 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29704127 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28610585 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27772514 |
| 72 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.26256791 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26152664 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24638849 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24503223 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23491416 |
| 77 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.22957692 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21000181 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18735145 |
| 80 | NFYA_21822215_ChIP-Seq_K562_Human | 1.17734584 |
| 81 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.15047332 |
| 82 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14775248 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14088373 |
| 84 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.13376731 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13169284 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13168657 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12953365 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12317613 |
| 89 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.12251398 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11255150 |
| 91 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.08923380 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07631419 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06633037 |
| 94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06482854 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05994615 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05885223 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.05812019 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04252764 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01124584 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00323326 |
| 101 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99846158 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98995644 |
| 103 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.98484213 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96781609 |
| 105 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94685952 |
| 106 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94255808 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94044388 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93778262 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93778262 |
| 110 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.92944159 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92299751 |
| 112 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92216975 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91789441 |
| 114 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90796861 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89537492 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 0.89477743 |
| 117 | EWS_26573619_Chip-Seq_HEK293_Human | 0.88746841 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87564087 |
| 119 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87026415 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86631234 |
| 121 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84128754 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83327950 |
| 123 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83308162 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82849197 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82008151 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81043301 |
| 127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78900301 |
| 128 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78491332 |
| 129 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.77114937 |
| 130 | AR_19668381_ChIP-Seq_PC3_Human | 0.77006832 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76688471 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76282229 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76026186 |
| 134 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.73702953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.03416565 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.75245157 |
| 3 | MP0003878_abnormal_ear_physiology | 4.49705924 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.49705924 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.74676979 |
| 6 | MP0009046_muscle_twitch | 3.32692698 |
| 7 | MP0009745_abnormal_behavioral_response | 3.20988484 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.15100255 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.10951667 |
| 10 | MP0002064_seizures | 3.01045183 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.86113185 |
| 12 | MP0004270_analgesia | 2.59856704 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.58009365 |
| 14 | * MP0000778_abnormal_nervous_system | 2.56567656 |
| 15 | MP0002822_catalepsy | 2.55051586 |
| 16 | MP0002272_abnormal_nervous_system | 2.53153804 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.47590319 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.43883598 |
| 19 | MP0001486_abnormal_startle_reflex | 2.32558380 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.24354192 |
| 21 | MP0002102_abnormal_ear_morphology | 2.20902164 |
| 22 | * MP0005391_vision/eye_phenotype | 2.19064494 |
| 23 | MP0002697_abnormal_eye_size | 2.16808796 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.09244424 |
| 25 | MP0001984_abnormal_olfaction | 2.06151399 |
| 26 | MP0002184_abnormal_innervation | 2.03028615 |
| 27 | MP0005197_abnormal_uvea_morphology | 1.99745428 |
| 28 | * MP0001502_abnormal_circadian_rhythm | 1.94560175 |
| 29 | MP0002736_abnormal_nociception_after | 1.93242128 |
| 30 | * MP0006072_abnormal_retinal_apoptosis | 1.85507757 |
| 31 | MP0004742_abnormal_vestibular_system | 1.82226064 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.80865953 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.76047540 |
| 34 | MP0008569_lethality_at_weaning | 1.69069225 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.66221699 |
| 36 | MP0005499_abnormal_olfactory_system | 1.66221699 |
| 37 | MP0004142_abnormal_muscle_tone | 1.65056346 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.64076240 |
| 39 | MP0004885_abnormal_endolymph | 1.61147896 |
| 40 | MP0001293_anophthalmia | 1.57966900 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.56343634 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.55302435 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.53224954 |
| 44 | MP0003011_delayed_dark_adaptation | 1.52566353 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.51278637 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.48487315 |
| 47 | MP0003879_abnormal_hair_cell | 1.46819823 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.44608886 |
| 49 | MP0001299_abnormal_eye_distance/ | 1.43099791 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.41842539 |
| 51 | MP0005248_abnormal_Harderian_gland | 1.40830373 |
| 52 | MP0000955_abnormal_spinal_cord | 1.39171728 |
| 53 | MP0003122_maternal_imprinting | 1.38716796 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 1.37823406 |
| 55 | * MP0002152_abnormal_brain_morphology | 1.36989069 |
| 56 | MP0003787_abnormal_imprinting | 1.36934460 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.36660271 |
| 58 | MP0004924_abnormal_behavior | 1.36303265 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.36303265 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.35865132 |
| 61 | MP0003329_amyloid_beta_deposits | 1.31885879 |
| 62 | * MP0005551_abnormal_eye_electrophysiolog | 1.31416968 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.29211152 |
| 64 | MP0004858_abnormal_nervous_system | 1.28387459 |
| 65 | MP0001970_abnormal_pain_threshold | 1.27459750 |
| 66 | MP0001919_abnormal_reproductive_system | 1.26027949 |
| 67 | MP0001188_hyperpigmentation | 1.23284898 |
| 68 | MP0000049_abnormal_middle_ear | 1.21414917 |
| 69 | MP0002233_abnormal_nose_morphology | 1.20784669 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.20255913 |
| 71 | MP0004215_abnormal_myocardial_fiber | 1.19008751 |
| 72 | MP0003633_abnormal_nervous_system | 1.18441513 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.18281206 |
| 74 | MP0002160_abnormal_reproductive_system | 1.14306513 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 1.14226178 |
| 76 | MP0003938_abnormal_ear_development | 1.12859496 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 1.11749745 |
| 78 | MP0001346_abnormal_lacrimal_gland | 1.11343356 |
| 79 | * MP0002752_abnormal_somatic_nervous | 1.10073358 |
| 80 | MP0001986_abnormal_taste_sensitivity | 1.09918845 |
| 81 | MP0001905_abnormal_dopamine_level | 1.08390087 |
| 82 | MP0001324_abnormal_eye_pigmentation | 1.08129357 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.07582380 |
| 84 | MP0004133_heterotaxia | 1.06963605 |
| 85 | MP0005187_abnormal_penis_morphology | 1.06701675 |
| 86 | * MP0005195_abnormal_posterior_eye | 1.06545461 |
| 87 | MP0002638_abnormal_pupillary_reflex | 1.06237246 |
| 88 | MP0001529_abnormal_vocalization | 1.04717878 |
| 89 | MP0001963_abnormal_hearing_physiology | 1.03407086 |
| 90 | MP0005646_abnormal_pituitary_gland | 1.02126881 |
| 91 | MP0003121_genomic_imprinting | 1.00334075 |
| 92 | MP0000751_myopathy | 0.99826045 |
| 93 | MP0003631_nervous_system_phenotype | 0.99531107 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.97513729 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.95701412 |
| 96 | MP0005647_abnormal_sex_gland | 0.94389770 |
| 97 | MP0003861_abnormal_nervous_system | 0.94359809 |
| 98 | MP0003123_paternal_imprinting | 0.94217858 |
| 99 | MP0008872_abnormal_physiological_respon | 0.92706216 |
| 100 | * MP0005253_abnormal_eye_physiology | 0.90306259 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.88469068 |
| 102 | MP0000566_synostosis | 0.87273573 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.87249721 |
| 104 | MP0003315_abnormal_perineum_morphology | 0.85588168 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.85506560 |
| 106 | MP0003632_abnormal_nervous_system | 0.83149108 |
| 107 | MP0001943_abnormal_respiration | 0.82992802 |
| 108 | MP0004085_abnormal_heartbeat | 0.81252313 |
| 109 | MP0002229_neurodegeneration | 0.80037108 |
| 110 | MP0005623_abnormal_meninges_morphology | 0.79373931 |
| 111 | MP0002092_abnormal_eye_morphology | 0.76930507 |
| 112 | * MP0003634_abnormal_glial_cell | 0.75081442 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.71823984 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.71540992 |
| 115 | MP0005389_reproductive_system_phenotype | 0.70497807 |
| 116 | MP0005171_absent_coat_pigmentation | 0.70035169 |
| 117 | MP0001764_abnormal_homeostasis | 0.69820182 |
| 118 | MP0004484_altered_response_of | 0.69599235 |
| 119 | MP0002909_abnormal_adrenal_gland | 0.69415502 |
| 120 | MP0002090_abnormal_vision | 0.69392906 |
| 121 | MP0002177_abnormal_outer_ear | 0.68471902 |
| 122 | MP0008058_abnormal_DNA_repair | 0.68426452 |
| 123 | * MP0001286_abnormal_eye_development | 0.67725969 |
| 124 | MP0010770_preweaning_lethality | 0.67105745 |
| 125 | MP0002082_postnatal_lethality | 0.67105745 |
| 126 | MP0000026_abnormal_inner_ear | 0.66720589 |
| 127 | MP0002081_perinatal_lethality | 0.66119922 |
| 128 | MP0001177_atelectasis | 0.65111937 |
| 129 | MP0000647_abnormal_sebaceous_gland | 0.63862704 |
| 130 | MP0010769_abnormal_survival | 0.62735269 |
| 131 | MP0004233_abnormal_muscle_weight | 0.62539590 |
| 132 | MP0002163_abnormal_gland_morphology | 0.61819797 |
| 133 | MP0003136_yellow_coat_color | 0.60823645 |
| 134 | MP0002938_white_spotting | 0.60795330 |
| 135 | MP0001145_abnormal_male_reproductive | 0.59496973 |
| 136 | MP0005193_abnormal_anterior_eye | 0.58656042 |
| 137 | MP0002111_abnormal_tail_morphology | 0.58539474 |
| 138 | MP0003755_abnormal_palate_morphology | 0.57328684 |
| 139 | MP0004197_abnormal_fetal_growth/weight/ | 0.56840217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.21916980 |
| 2 | Hyperventilation (HP:0002883) | 5.64005890 |
| 3 | Chronic hepatic failure (HP:0100626) | 5.54300346 |
| 4 | Atonic seizures (HP:0010819) | 5.43506164 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.10010714 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.99116919 |
| 7 | Focal seizures (HP:0007359) | 4.85182057 |
| 8 | Vitreoretinal degeneration (HP:0000655) | 4.83813097 |
| 9 | Intestinal atresia (HP:0011100) | 4.52972977 |
| 10 | Febrile seizures (HP:0002373) | 4.29308196 |
| 11 | Oligodactyly (hands) (HP:0001180) | 4.19652743 |
| 12 | Tubulointerstitial nephritis (HP:0001970) | 4.16964686 |
| 13 | High anterior hairline (HP:0009890) | 4.07304563 |
| 14 | Broad-based gait (HP:0002136) | 3.95095729 |
| 15 | Visual hallucinations (HP:0002367) | 3.93129308 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.89797081 |
| 17 | Absence seizures (HP:0002121) | 3.80984530 |
| 18 | Dialeptic seizures (HP:0011146) | 3.78051368 |
| 19 | Hyperthyroidism (HP:0000836) | 3.65910811 |
| 20 | Chin dimple (HP:0010751) | 3.65794976 |
| 21 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.60654456 |
| 22 | Short 4th metacarpal (HP:0010044) | 3.60654456 |
| 23 | Chorioretinal atrophy (HP:0000533) | 3.60011347 |
| 24 | Partial agenesis of the corpus callosum (HP:0001338) | 3.45549340 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 3.37041132 |
| 26 | Myokymia (HP:0002411) | 3.34183928 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.33783976 |
| 28 | Neonatal short-limb short stature (HP:0008921) | 3.31627007 |
| 29 | Oligodactyly (HP:0012165) | 3.14393483 |
| 30 | Insidious onset (HP:0003587) | 3.13974487 |
| 31 | Termporal pattern (HP:0011008) | 3.13974487 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 3.13780662 |
| 33 | Sclerocornea (HP:0000647) | 3.11583863 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 3.10951494 |
| 35 | Truncal ataxia (HP:0002078) | 3.08228455 |
| 36 | Cortical dysplasia (HP:0002539) | 3.08008222 |
| 37 | Central scotoma (HP:0000603) | 3.04570031 |
| 38 | Progressive macrocephaly (HP:0004481) | 3.03645132 |
| 39 | Anophthalmia (HP:0000528) | 3.02119398 |
| 40 | Amblyopia (HP:0000646) | 3.01309083 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.97858035 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.97858035 |
| 43 | Severe Myopia (HP:0011003) | 2.97541508 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.96986156 |
| 45 | Excessive salivation (HP:0003781) | 2.96705974 |
| 46 | Drooling (HP:0002307) | 2.96705974 |
| 47 | Double outlet right ventricle (HP:0001719) | 2.94231746 |
| 48 | Congenital malformation of the right heart (HP:0011723) | 2.94231746 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.85711016 |
| 50 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.83773383 |
| 51 | Abnormal hair whorl (HP:0010721) | 2.81512706 |
| 52 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.79580630 |
| 53 | Thyroiditis (HP:0100646) | 2.73404880 |
| 54 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.73053433 |
| 55 | Hypoplasia of the iris (HP:0007676) | 2.72483484 |
| 56 | Hemiparesis (HP:0001269) | 2.71556960 |
| 57 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.69592790 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 2.69155740 |
| 59 | Abnormality of glycolysis (HP:0004366) | 2.66504702 |
| 60 | Increased serum pyruvate (HP:0003542) | 2.66504702 |
| 61 | Chorioretinal coloboma (HP:0000567) | 2.64392037 |
| 62 | Pheochromocytoma (HP:0002666) | 2.63642305 |
| 63 | Poor eye contact (HP:0000817) | 2.61606045 |
| 64 | Abnormality of the 4th metacarpal (HP:0010012) | 2.61538488 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.57992692 |
| 66 | Renovascular hypertension (HP:0100817) | 2.57946902 |
| 67 | Labial hypoplasia (HP:0000066) | 2.49734448 |
| 68 | Progressive inability to walk (HP:0002505) | 2.48864616 |
| 69 | Acute encephalopathy (HP:0006846) | 2.48612892 |
| 70 | Facial cleft (HP:0002006) | 2.43753546 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 2.42653376 |
| 72 | Tubulointerstitial abnormality (HP:0001969) | 2.42288900 |
| 73 | Inability to walk (HP:0002540) | 2.39562636 |
| 74 | Impaired social interactions (HP:0000735) | 2.38492461 |
| 75 | Abnormal social behavior (HP:0012433) | 2.38492461 |
| 76 | Abnormality of the parathyroid morphology (HP:0011766) | 2.37712049 |
| 77 | Mitochondrial inheritance (HP:0001427) | 2.36780912 |
| 78 | Hypoplastic female external genitalia (HP:0012815) | 2.36479784 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.35123399 |
| 80 | * Pendular nystagmus (HP:0012043) | 2.34776904 |
| 81 | Esophageal atresia (HP:0002032) | 2.33463295 |
| 82 | Protruding tongue (HP:0010808) | 2.31026990 |
| 83 | Shoulder girdle muscle weakness (HP:0003547) | 2.28739743 |
| 84 | Postaxial foot polydactyly (HP:0001830) | 2.27553519 |
| 85 | Absent radius (HP:0003974) | 2.26791770 |
| 86 | Dysmetria (HP:0001310) | 2.21506790 |
| 87 | Scotoma (HP:0000575) | 2.21307527 |
| 88 | Decreased central vision (HP:0007663) | 2.19082080 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 2.16858922 |
| 90 | Absent forearm bone (HP:0003953) | 2.15954300 |
| 91 | Aplasia involving forearm bones (HP:0009822) | 2.15954300 |
| 92 | Anosmia (HP:0000458) | 2.15243592 |
| 93 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14688824 |
| 94 | Optic disc pallor (HP:0000543) | 2.14146441 |
| 95 | Dysmetric saccades (HP:0000641) | 2.14046072 |
| 96 | EEG with generalized epileptiform discharges (HP:0011198) | 2.12968942 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.12293059 |
| 98 | Scanning speech (HP:0002168) | 2.12157808 |
| 99 | Abnormality of the labia (HP:0000058) | 2.12102528 |
| 100 | Heterochromia iridis (HP:0001100) | 2.11959938 |
| 101 | Agitation (HP:0000713) | 2.11570841 |
| 102 | Failure to thrive in infancy (HP:0001531) | 2.11277379 |
| 103 | Abnormality of the labia minora (HP:0012880) | 2.10132404 |
| 104 | Molar tooth sign on MRI (HP:0002419) | 2.09460037 |
| 105 | Abnormality of midbrain morphology (HP:0002418) | 2.09460037 |
| 106 | Type II diabetes mellitus (HP:0005978) | 2.08471355 |
| 107 | Action tremor (HP:0002345) | 2.07935911 |
| 108 | Growth hormone deficiency (HP:0000824) | 2.07738926 |
| 109 | Rib fusion (HP:0000902) | 2.07441026 |
| 110 | Status epilepticus (HP:0002133) | 2.05891379 |
| 111 | Urinary urgency (HP:0000012) | 2.04776969 |
| 112 | Genetic anticipation (HP:0003743) | 2.04325352 |
| 113 | Retinal dysplasia (HP:0007973) | 2.03632170 |
| 114 | Polyphagia (HP:0002591) | 2.03586958 |
| 115 | Atrioventricular canal defect (HP:0006695) | 2.03284024 |
| 116 | Annular pancreas (HP:0001734) | 2.02313178 |
| 117 | Depression (HP:0000716) | 2.00975681 |
| 118 | Dyschromatopsia (HP:0007641) | 2.00714466 |
| 119 | Abnormal pupillary function (HP:0007686) | 1.99330281 |
| 120 | Anxiety (HP:0000739) | 1.99233998 |
| 121 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.99044318 |
| 122 | Hypsarrhythmia (HP:0002521) | 1.99032635 |
| 123 | Anencephaly (HP:0002323) | 1.98736960 |
| 124 | Bicornuate uterus (HP:0000813) | 1.96868792 |
| 125 | Down-sloping shoulders (HP:0200021) | 1.96798338 |
| 126 | Abnormality of salivation (HP:0100755) | 1.95577147 |
| 127 | Exotropia (HP:0000577) | 1.95533006 |
| 128 | True hermaphroditism (HP:0010459) | 1.94609660 |
| 129 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94220908 |
| 130 | Obsessive-compulsive behavior (HP:0000722) | 1.93462519 |
| 131 | Narrow nasal bridge (HP:0000446) | 1.93328488 |
| 132 | Renal hypoplasia (HP:0000089) | 1.91779045 |
| 133 | Abnormality of binocular vision (HP:0011514) | 1.91671792 |
| 134 | Diplopia (HP:0000651) | 1.91671792 |
| 135 | Increased CSF lactate (HP:0002490) | 1.91544853 |
| 136 | Congenital hepatic fibrosis (HP:0002612) | 1.90756493 |
| 137 | Natal tooth (HP:0000695) | 1.90405975 |
| 138 | Absent speech (HP:0001344) | 1.88648967 |
| 139 | Hepatocellular necrosis (HP:0001404) | 1.88371129 |
| 140 | Impaired smooth pursuit (HP:0007772) | 1.88250764 |
| 141 | Cutaneous finger syndactyly (HP:0010554) | 1.88138834 |
| 142 | Lissencephaly (HP:0001339) | 1.86902242 |
| 143 | Gait imbalance (HP:0002141) | 1.85600244 |
| 144 | Leukodystrophy (HP:0002415) | 1.84177969 |
| 145 | Complete atrioventricular canal defect (HP:0001674) | 1.83715632 |
| 146 | Specific learning disability (HP:0001328) | 1.83479175 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.83120217 |
| 148 | Mixed hearing impairment (HP:0000410) | 1.82300678 |
| 149 | Hypoplasia of the ulna (HP:0003022) | 1.79554080 |
| 150 | Spastic gait (HP:0002064) | 1.79368261 |
| 151 | Short chin (HP:0000331) | 1.78434370 |
| 152 | Short thumb (HP:0009778) | 1.78030190 |
| 153 | Spastic diplegia (HP:0001264) | 1.77163102 |
| 154 | Type II lissencephaly (HP:0007260) | 1.76302411 |
| 155 | Abnormality of macular pigmentation (HP:0008002) | 1.76007523 |
| 156 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.75510057 |
| 157 | Cerebral inclusion bodies (HP:0100314) | 1.75028983 |
| 158 | Abnormality of the lower motor neuron (HP:0002366) | 1.74534408 |
| 159 | Enlarged kidneys (HP:0000105) | 1.73876730 |
| 160 | X-linked dominant inheritance (HP:0001423) | 1.73286651 |
| 161 | Omphalocele (HP:0001539) | 1.73202959 |
| 162 | Subcapsular cataract (HP:0000523) | 1.69719716 |
| 163 | Cystic hygroma (HP:0000476) | 1.69557108 |
| 164 | Synostosis of carpal bones (HP:0005048) | 1.68823284 |
| 165 | Fibular hypoplasia (HP:0003038) | 1.68795038 |
| 166 | Gait ataxia (HP:0002066) | 1.68506082 |
| 167 | Stereotypic behavior (HP:0000733) | 1.67417131 |
| 168 | Rimmed vacuoles (HP:0003805) | 1.67368033 |
| 169 | Flattened epiphyses (HP:0003071) | 1.67257034 |
| 170 | Insomnia (HP:0100785) | 1.67199900 |
| 171 | Lower limb asymmetry (HP:0100559) | 1.67190102 |
| 172 | * Esotropia (HP:0000565) | 1.66932931 |
| 173 | Bifid scrotum (HP:0000048) | 1.66097341 |
| 174 | Thickened helices (HP:0000391) | 1.65766133 |
| 175 | * Iris coloboma (HP:0000612) | 1.65645292 |
| 176 | Pointed chin (HP:0000307) | 1.64724156 |
| 177 | Deep palmar crease (HP:0006191) | 1.64622976 |
| 178 | Resting tremor (HP:0002322) | 1.64281637 |
| 179 | Incomplete penetrance (HP:0003829) | 1.63670685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.45572270 |
| 2 | NTRK3 | 3.66698697 |
| 3 | DAPK2 | 3.54531154 |
| 4 | TLK1 | 3.38146156 |
| 5 | MAP4K2 | 3.11986674 |
| 6 | MAP3K12 | 3.03068840 |
| 7 | EPHA4 | 2.88605212 |
| 8 | PNCK | 2.52273777 |
| 9 | DAPK1 | 2.51201781 |
| 10 | CAMKK2 | 2.42808107 |
| 11 | PINK1 | 2.42618220 |
| 12 | STK16 | 2.29675972 |
| 13 | TESK2 | 2.26168511 |
| 14 | MAP3K4 | 2.12255073 |
| 15 | PLK2 | 2.00560148 |
| 16 | CDK19 | 2.00021407 |
| 17 | CCNB1 | 1.89219062 |
| 18 | NTRK2 | 1.87227936 |
| 19 | KSR1 | 1.86747971 |
| 20 | DYRK2 | 1.84280201 |
| 21 | MARK1 | 1.82966182 |
| 22 | INSRR | 1.74478365 |
| 23 | MAP2K7 | 1.69551164 |
| 24 | DAPK3 | 1.69543630 |
| 25 | MINK1 | 1.68839633 |
| 26 | MAPK15 | 1.67922759 |
| 27 | EIF2AK3 | 1.55970819 |
| 28 | DYRK1B | 1.52334497 |
| 29 | AKT3 | 1.50935486 |
| 30 | NUAK1 | 1.50487977 |
| 31 | CSNK1G1 | 1.50266007 |
| 32 | PAK3 | 1.42839778 |
| 33 | MAP2K4 | 1.42660838 |
| 34 | MKNK2 | 1.41530375 |
| 35 | MAP3K9 | 1.41036093 |
| 36 | CAMKK1 | 1.39109821 |
| 37 | ZAK | 1.36073366 |
| 38 | VRK1 | 1.32308424 |
| 39 | OXSR1 | 1.31842811 |
| 40 | BCR | 1.31400684 |
| 41 | DYRK3 | 1.30192504 |
| 42 | MAP3K6 | 1.29397676 |
| 43 | WNK4 | 1.28185664 |
| 44 | ERBB2 | 1.27062390 |
| 45 | BUB1 | 1.25207849 |
| 46 | MAPK13 | 1.22073011 |
| 47 | MKNK1 | 1.20059854 |
| 48 | DYRK1A | 1.16742423 |
| 49 | NME1 | 1.14738439 |
| 50 | TNIK | 1.11028821 |
| 51 | ICK | 1.07453940 |
| 52 | PAK6 | 1.06721356 |
| 53 | SRPK1 | 1.04257401 |
| 54 | LATS1 | 1.03731951 |
| 55 | SGK494 | 1.02983454 |
| 56 | SGK223 | 1.02983454 |
| 57 | GRK5 | 1.00817439 |
| 58 | CDK5 | 0.99923777 |
| 59 | FGFR2 | 0.98510602 |
| 60 | PRKCG | 0.98181491 |
| 61 | PLK4 | 0.95972354 |
| 62 | RIPK4 | 0.94262427 |
| 63 | STK38 | 0.93586344 |
| 64 | FGR | 0.92364954 |
| 65 | STK38L | 0.90604861 |
| 66 | MAP3K5 | 0.87886784 |
| 67 | SIK1 | 0.86932476 |
| 68 | CAMK2A | 0.86673375 |
| 69 | EPHB2 | 0.86587673 |
| 70 | PKN1 | 0.85624865 |
| 71 | PRKD2 | 0.83724361 |
| 72 | UHMK1 | 0.83600410 |
| 73 | ADRBK2 | 0.82896643 |
| 74 | AURKA | 0.81104914 |
| 75 | DMPK | 0.78093668 |
| 76 | CAMK2B | 0.76718707 |
| 77 | MAP3K2 | 0.75953189 |
| 78 | CDK14 | 0.74895570 |
| 79 | ROCK2 | 0.74800053 |
| 80 | ARAF | 0.74020460 |
| 81 | TAOK1 | 0.73296611 |
| 82 | PHKG2 | 0.73206622 |
| 83 | PHKG1 | 0.73206622 |
| 84 | CDK18 | 0.73156016 |
| 85 | CDK9 | 0.71795337 |
| 86 | SIK2 | 0.70342675 |
| 87 | CDK15 | 0.69077344 |
| 88 | CAMK1G | 0.68612273 |
| 89 | SGK1 | 0.68294310 |
| 90 | KSR2 | 0.68116372 |
| 91 | MAP3K11 | 0.67233945 |
| 92 | PRKCZ | 0.66661401 |
| 93 | BMPR1B | 0.66641588 |
| 94 | PRKCE | 0.65886468 |
| 95 | TSSK6 | 0.65801443 |
| 96 | PRPF4B | 0.64702102 |
| 97 | RPS6KB1 | 0.64504907 |
| 98 | RIPK1 | 0.61420341 |
| 99 | ADRBK1 | 0.60684119 |
| 100 | SGK2 | 0.60220260 |
| 101 | LATS2 | 0.60196821 |
| 102 | RPS6KA5 | 0.58922593 |
| 103 | PTK2B | 0.58462221 |
| 104 | CDC7 | 0.58359126 |
| 105 | PRKCQ | 0.58196867 |
| 106 | PBK | 0.57886446 |
| 107 | FES | 0.55493078 |
| 108 | STK11 | 0.55322812 |
| 109 | CDK11A | 0.54574789 |
| 110 | FER | 0.52366796 |
| 111 | CSNK1G2 | 0.51241295 |
| 112 | IRAK2 | 0.50361466 |
| 113 | CSNK1A1 | 0.49021051 |
| 114 | NTRK1 | 0.48480322 |
| 115 | FRK | 0.47778191 |
| 116 | MUSK | 0.47374013 |
| 117 | MARK2 | 0.47202253 |
| 118 | GSK3A | 0.47082148 |
| 119 | AURKB | 0.46923013 |
| 120 | BRSK2 | 0.46921083 |
| 121 | WNK3 | 0.45685934 |
| 122 | STK4 | 0.45494096 |
| 123 | BMPR2 | 0.45445072 |
| 124 | STK39 | 0.44765295 |
| 125 | PRKACA | 0.43719780 |
| 126 | RPS6KA6 | 0.42104098 |
| 127 | MATK | 0.41569409 |
| 128 | ATR | 0.41099002 |
| 129 | PDK3 | 0.40969588 |
| 130 | PDK4 | 0.40969588 |
| 131 | CSNK1D | 0.39922202 |
| 132 | PRKAA1 | 0.39755493 |
| 133 | RET | 0.39258143 |
| 134 | RPS6KA3 | 0.39060242 |
| 135 | RAF1 | 0.39031097 |
| 136 | MYLK | 0.38810948 |
| 137 | RPS6KC1 | 0.38738814 |
| 138 | RPS6KL1 | 0.38738814 |
| 139 | CAMK2G | 0.38600027 |
| 140 | PIK3CA | 0.38382571 |
| 141 | SIK3 | 0.37966943 |
| 142 | CSNK1A1L | 0.37848087 |
| 143 | CSNK1G3 | 0.37635512 |
| 144 | BRAF | 0.37413292 |
| 145 | CAMK2D | 0.36724576 |
| 146 | CAMK4 | 0.36569907 |
| 147 | WNK1 | 0.35729265 |
| 148 | ERBB3 | 0.35077266 |
| 149 | CSNK1E | 0.34916325 |
| 150 | TYRO3 | 0.34900016 |
| 151 | CAMK1 | 0.34357480 |
| 152 | MTOR | 0.34292415 |
| 153 | PLK3 | 0.33798863 |
| 154 | MAPK10 | 0.33178668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.31229968 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 3.86270763 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.46308470 |
| 4 | Alcoholism_Homo sapiens_hsa05034 | 3.42632969 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.31023858 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.98699934 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.68744333 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.65167937 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39216580 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36812333 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31251625 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.17272421 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.14132928 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13786623 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.13539951 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00173241 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.97689340 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.89755594 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89441061 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.87219456 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.85803781 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.83056873 |
| 23 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.78442449 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.77530245 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.71210629 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.69195190 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66667592 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.66366360 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61480723 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57870288 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.55874005 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53490811 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.52826077 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45071717 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43170717 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.41780600 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41216811 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35996197 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35795559 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31118349 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29799147 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28317081 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26007026 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20948476 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20146819 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19279876 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17547160 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17068210 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.16880598 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16262854 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 1.11874823 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09424459 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08664708 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07964954 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06764571 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04817252 |
| 57 | Glioma_Homo sapiens_hsa05214 | 1.04466273 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.02801211 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 1.01821361 |
| 60 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.95121223 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94985423 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93990076 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93178396 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92148829 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91815623 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84939400 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84443021 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83374833 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.83007076 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81899799 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81235176 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77759172 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75112182 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.75030281 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.74452883 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74112903 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72017993 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71748986 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71529186 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69334422 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.69198112 |
| 82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67258926 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66935698 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66517054 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65943732 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65704082 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64225220 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63052617 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63038315 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62237895 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62175929 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61635160 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60372593 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.60041010 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58316233 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56830905 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56769999 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55608720 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55493373 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55228776 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55109298 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54198880 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52940716 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50898304 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48812466 |
| 106 | Cell cycle_Homo sapiens_hsa04110 | 0.48565442 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48052545 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47999510 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47809838 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46539138 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46384735 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46294480 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44917390 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44851309 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44339818 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.44221400 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43510561 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41954348 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41939587 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41022763 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36973144 |
| 122 | RNA polymerase_Homo sapiens_hsa03020 | 0.36458560 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36392944 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.35770536 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.34795511 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34785846 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34020156 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33823354 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.33101298 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32990527 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32801576 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32151535 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31594255 |
| 134 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30499362 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29947140 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28637379 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.28000213 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26621056 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25790880 |
| 140 | Homologous recombination_Homo sapiens_hsa03440 | 0.25396291 |
| 141 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24613309 |
| 142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24448999 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23175417 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23153204 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22501597 |

